NCT04127474

Brief Summary

To assess the demographic variables, periodontal parameters and to determine the expression of Trefoil factors 2 and 3 and Adrenomedullin in unstimulated saliva samples of periodontally healthy subjects with coronary heart disease and generalised chronic periodontitis subjects with and without coronary heart disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

October 14, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 15, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2020

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2021

Completed
Last Updated

September 2, 2020

Status Verified

September 1, 2020

Enrollment Period

1.2 years

First QC Date

October 14, 2019

Last Update Submit

September 1, 2020

Conditions

Keywords

periodontitissalivatrefoil factoradrenomedullinCoronary heart disease

Outcome Measures

Primary Outcomes (1)

  • Trefoil factors 2 and 3 and Adrenomedullin expression in Chronic periodontitis patients with and without coronary heart disease

    Expression of Trefoil factors 2 and 3 and Adrenomedullin using Enzyme Linked Immunosorbent Assay

    12 months

Study Arms (3)

Group I

25 Generalized chronic periodontitis subjects without coronary heart disease.

Group II

25 Generalized chronic periodontitis subjects diagnosed with coronary heart disease.

Group III

25 Periodontally healthy subjects diagnosed with coronary heart disease.

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants from 30 years to 65 years will be recruited for the study. Subjects would be categorized into the above mentioned three groups based on their medical status.

You may qualify if:

  • Patients willing to participate in the study.
  • Patients within the age group of 30-65 years.
  • Patients should have ≥ 20 remaining natural teeth.
  • For Group I
  • Systemically healthy, Generalized chronic periodontitis subjects with 30% or more sites with clinical attachment loss (CAL) ≥ 2mm, radiographic evidence of alveolar crestal bone loss ≥ 2mm from the cemento-enamel junction.
  • For Group II
  • Generalized chronic periodontitis subjects with 30% or more sites with clinical attachment loss (CAL) ≥ 2mm, radiographic evidence of alveolar crestal bone loss ≥ 2mm from the cemento-enamel junction along with coronary heart disease.
  • For Group III • Periodontally healthy subjects with Probing pocket depth (PD) less than 4mm, bleeding on probing (BOP) at ≤15% of tooth sites, no periodontal treatment (Scaling and root planing or periodontal surgery) within the previous 6 months and without evident clinical signs of gingival inflammation along with the presence of coronary heart disease.

You may not qualify if:

  • Subjects with systemic conditions such as type I and type II diabetes mellitus, respiratory diseases, renal disease, liver disease, rheumatoid arthritis, allergy, advanced malignancies and HIV infection will be excluded from the present investigation.
  • For Group I, subjects on drugs such as corticosteroids, antibiotics, within 6 months of investigation will be excluded.
  • Current smokers and individuals who quit smoking less than 6 months.
  • Patients who have undergone periodontal therapy within the previous 6 months.
  • Pregnant women (pregnancy may alter the oral flora)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meenakshi Ammal Dental College

Chennai, Tamil Nadu, 600095, India

RECRUITING

Related Publications (2)

  • Chaiyarit P, Chayasadom A, Wara-Aswapati N, Hormdee D, Sittisomwong S, Nakaresisoon S, Samson MH, Pitiphat W, Giraud AS. Trefoil factors in saliva and gingival tissues of patients with chronic periodontitis. J Periodontol. 2012 Sep;83(9):1129-38. doi: 10.1902/jop.2011.110431. Epub 2011 Dec 19.

    PMID: 22181686BACKGROUND
  • Suchetha A, Garg A, Lakshmi P, Bhat D, Sapna N, Apoorva SM. Adrenomedullin, periodontitis, diabetes-unraveling the equivocal relationship: A clinicobiochemical cross-sectional study. Contemp Clin Dent. 2013 Oct;4(4):454-9. doi: 10.4103/0976-237X.123040.

    PMID: 24403788BACKGROUND

MeSH Terms

Conditions

Coronary DiseasePeriodontal DiseasesPeriodontitis

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Jaideep Mahendra, MDS, PhD

    Meenakshi Ammal Dental College

    STUDY DIRECTOR

Central Study Contacts

Jaideep Mahendra, MDS, PhD

CONTACT

Sruthi Srinivasan, BDS

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, PhD guide, Director of Post Graduate Studies

Study Record Dates

First Submitted

October 14, 2019

First Posted

October 15, 2019

Study Start

October 14, 2019

Primary Completion

December 20, 2020

Study Completion

November 20, 2021

Last Updated

September 2, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations